The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
|Videos|November 16, 2022
Premium Empty Hard Capsules – EMBO CAPS® is for companies that want the best
Author(s)Embocaps® by Suheung
Key Learning Objectives
- EMBO CAPS® is the best empty hard capsule you can buy and understand why it is worth the money
- EMBO CAPS® has a very solid presence in Europe and is a reliable partner
- EMBO CAPS® is continuously investing to defend our quality leadership and be prepared for the future
Related to this article
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
FDA approved pimicotinib for TGCT based on a 56% response rate; its Project Orbis review signals tighter global launch planning for manufacturers.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
From AI validation to microstructure imaging, AAPS PharmSci 360 speakers pushed toward faster drug development backed by stronger evidence. Here are PharmTech's biggest takeaways.
Trending on Pharmaceutical Technology
1
Pimicotinib TGCT Approval Shows How Assessment Aid Supports Review
2
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
3
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
4
Our Biggest Takeaways From AAPS PharmSci 360
5